Conference Summary

This FASEB Science Research Conference (SRC) will cover basic mechanisms of mitochondrial function, biogenesis, and dynamics as well as their contribution to physiology and pathology, focusing on metabolic diseases, immunology, and cancer.

This conference will bring together scientists from academia and industry who study and aim to identify new points of intervention for metabolic diseases and to exploit the immune system to cure diseases, as well as academic scientists interested in basic mechanisms of mitochondrial physiology. 

The main themes of this meeting are: 1) Building the mitochondria; 2) Different aspects of mitochondrial turnover in health and disease; 3) Mitochondria as integrators of cellular metabolism; 4) Mitochondria-derived signaling.

The conference will present:

  • Mitochondria gene expression
  • Respiratory chain assembly
  • Mechanisms of mitochondrial quality control and turnover
  • Mechanisms of mitochondrial fusion, fission and motility
  • Mitochondria export and delivery
  • Mitochondrial fuel preference and oxidation in metabolic diseases
  • Role of mitochondria in immune cell metabolism
  • Mitochondria-derived signaling

The keynote lecture will be presented by Paolo Bernardi, MD (University of Padova). The conference will feature 36 talks and 18 shorts talks selected from abstracts, four poster sessions, and a career development session, “Evolving Opportunities in Biotech, Pharma and Academia for Mitochondria Science.”


Registration Prices


    Sign Up for Emails


    Conference Location

    Omni Rancho Las Palmas Resort
    41000 Bob Hope Drive
    Rancho Mirage, California 92270 USA



    Conference Organizers

    Orian Shirihai, MD, PhD
    Director, Metabolism Unified Research Theme, David Geffen School of Medicine, and Professor of Medicine (Endocrinology) and Molecular & Medical Pharmacology, University of California, Los Angeles, USA

    Marc Liesa-Roig, PhD
    Assistant Professor in-residence, Department of Medicine, Division of Endocrinology, and the Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, USA

    José Antonio Enríquez, PhD
    Full Professor, University of Zaragoza and Senior Researcher, National Center for Cardiovascular Investigations (CNIC), Madrid, Spain

    Pere Puigserver, PhD
    Professor, Cell Biology, Harvard University, and Professor, Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA


    Keynote Speaker

    Paolo Bernardi, MD
    University of Padova